Ascendis Pharma A (ASND) Return on Capital Employed Growth (1y) (2016 - 2026)
Ascendis Pharma A (ASND) Return on Capital Employed Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 2,400.00 |
| 10 | Ascendis Pharma A | 15.55 Bn | 14.88 Bn | 268.20 Mn | -3.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.13 Mn |
| Dec 31, 2025 | -2.75 Mn |
| Sep 30, 2025 | 29.80 Mn |
| Jun 30, 2025 | 35.32 Mn |
| Mar 31, 2025 | 3.45 Mn |
| Dec 31, 2024 | 2.78 Mn |
| Sep 30, 2024 | -30,151.00 |
| Jun 30, 2024 | 63,650.00 |
| Mar 31, 2024 | -318,050.00 |
| Dec 31, 2023 | -33,068.00 |
| Sep 30, 2023 | -4,006.00 |
| Jun 30, 2023 | -4,003.00 |
| Mar 31, 2023 | -4,062.00 |
| Dec 31, 2022 | -2,726.00 |
| Sep 30, 2022 | 65.00 |
| Jun 30, 2022 | 966.00 |
| Mar 31, 2022 | 150.00 |
| Dec 31, 2021 | -643.00 |
| Sep 30, 2021 | -809.00 |
| Jun 30, 2021 | 208.00 |